metoclopramide has been researched along with Alcoholism in 6 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Alcoholism: A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The potent serotonin receptor (5-HT3) antagonists are new highly selective agents for the prevention and control of chemotherapy-induced nausea and vomiting that have been shown to be comparable to or more effective than traditional metoclopramide regimens." | 9.08 | A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy. ( Bastit, P; Cals, L; Cappelaere, P; Catimel, G; Chevallier, B; Claverie, N; Fabbro, M; Giovannini, M; Khayat, D; Splinter, T; Wendling, JL, 1997) |
| "The potent serotonin receptor (5-HT3) antagonists are new highly selective agents for the prevention and control of chemotherapy-induced nausea and vomiting that have been shown to be comparable to or more effective than traditional metoclopramide regimens." | 5.08 | A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy. ( Bastit, P; Cals, L; Cappelaere, P; Catimel, G; Chevallier, B; Claverie, N; Fabbro, M; Giovannini, M; Khayat, D; Splinter, T; Wendling, JL, 1997) |
| "To assess the possible influence of alcoholism on the dopaminergic inhibitory control of prolactin (PRL) secretion, 10 mg of the dopaminergic antagonist metoclopramide (MTC), was injected i." | 5.08 | Effects of thyrotropin-releasing hormone and metoclopramide on PRL secretion in normally cycling and amenorrheic alcoholic women. ( Coiro, V; Vescovi, PP, 1997) |
| "The prolactin response to oral metoclopramide (10 mg) was investigated in 53 chronic alcoholics (26 with alcoholic cirrhosis and 27 without evidence of liver disease) from two to seven days after alcohol suspension." | 3.66 | Increased prolactin reserve in alcoholics. ( Basile, A; Cartisano, D; Cella, R; Geatti, O; Laperchia, N; Nador, G; Proto, G, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Röjdmark, S | 1 |
| Adner, N | 1 |
| Andersson, DE | 1 |
| Austern, J | 1 |
| Lamminpää, K | 1 |
| Basile, A | 1 |
| Proto, G | 1 |
| Laperchia, N | 1 |
| Cella, R | 1 |
| Cartisano, D | 1 |
| Nador, G | 1 |
| Geatti, O | 1 |
| Chevallier, B | 1 |
| Cappelaere, P | 1 |
| Splinter, T | 1 |
| Fabbro, M | 1 |
| Wendling, JL | 1 |
| Cals, L | 1 |
| Catimel, G | 1 |
| Giovannini, M | 1 |
| Khayat, D | 1 |
| Bastit, P | 1 |
| Claverie, N | 1 |
| Vescovi, PP | 1 |
| Coiro, V | 1 |
| Salim, AS | 1 |
| Tønnesen, H | 1 |
| Andersen, JR | 1 |
| Christoffersen, P | 1 |
| Kaas-Claesson, N | 1 |
4 trials available for metoclopramide and Alcoholism
| Article | Year |
|---|---|
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
Topics: Acute Disease; Alcoholism; Antiemetics; Antineoplastic Agents; Basal Ganglia Diseases; Cisplatin; Do | 1997 |
Effects of thyrotropin-releasing hormone and metoclopramide on PRL secretion in normally cycling and amenorrheic alcoholic women.
Topics: Adult; Alcoholism; Amenorrhea; Dopamine Antagonists; Female; Humans; Menstrual Cycle; Metoclopramide | 1997 |
Role of oxygen-derived free radical scavengers in the treatment of recurrent pain produced by chronic pancreatitis. A new approach.
Topics: Abdominal Pain; Adult; Aged; Alcoholism; Allopurinol; Chronic Disease; Dimethyl Sulfoxide; Double-Bl | 1991 |
Reflux oesophagitis in heavy drinkers. Effect of ranitidine and alginate/metoclopramide.
Topics: Adult; Alcoholism; Alginates; Double-Blind Method; Drug Therapy, Combination; Esophagitis, Peptic; E | 1987 |
2 other studies available for metoclopramide and Alcoholism
| Article | Year |
|---|---|
Prolactin and thyrotropin responses to thyrotropin-releasing hormone and metoclopramide in men with chronic alcoholism.
Topics: Adult; Aged; Alcoholism; Blood Glucose; Estradiol; Humans; Hydrocortisone; Male; Metoclopramide; Mid | 1984 |
Increased prolactin reserve in alcoholics.
Topics: Adult; Aged; Alcoholism; Female; Humans; Liver Cirrhosis, Alcoholic; Male; Metoclopramide; Middle Ag | 1981 |